Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novo Nordisk released new data on Tuesday that could help boost the case for the higher dose version of its blockbuster obesity injection Wegovy. It comes just one month after the launch of that 7.2-milligram shot in the U.S. …